Acebrophylline was initially approved by the United States Food and Drug Administration (FDA) on 4th Jan 2006. 

Acebrophylline is used to manage respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

To use Acebrophylline, follow the instructions provided by your healthcare provider or as indicated on the medication label. Swallow them whole with a full glass of water, with or without food, as directed. The dosage and duration of treatment will depend on the type and severity of the infection.

Common side effects of acebrophylline may include gastrointestinal disturbances such as nausea, vomiting, and abdominal discomfort. Other commonly reported side effects include headache, dizziness, heartburn, and changes in taste sensation. Less frequently, individuals may experience insomnia, tremors, palpitations, and allergic reactions such as rash or itching.

Acebrophylline carries important warnings that should be considered when using the medication. Hypersensitivity reactions, including skin rash and difficulty breathing. This medication can cause cardiac effects such as increased heart rate, palpitations, and arrhythmias are possible, and caution is advised in individuals with cardiac conditions. This medication may lower the seizure threshold, necessitating close monitoring in patients with a history of seizures. The medication may exacerbate gastrointestinal disorders. It should not be used for acute asthma or COPD exacerbations. Abrupt discontinuation can lead to withdrawal symptoms.

When using Acebrophylline, it is important to be aware of potential warnings. It is important to be aware of these potential skin reactions, seek medical help if any skin changes occur, monitor for these symptoms, and contact a healthcare provider if they arise. Caution is recommended in individuals with peptic ulcers or GERD. Vigilance and prompt reporting of new or worsening symptoms are essential to ensure Acebrophylline's safe and effective use. Contact your healthcare provider if you experience cardiac disease or seizures. Regular monitoring of respiratory function is essential to assess treatment effectiveness. Avoid alcohol consumption while taking Acebrophylline, as it can interact with the medication and potentially increase the risk of side effects. Adhering to these precautions and following your healthcare provider's guidance can help ensure Acebrophylline's safe and effective use.

Inform your healthcare provider about any known allergies or sensitivities to Acebrophylline and any other medications or substances you are currently taking. Additionally, disclose your medical history, especially if you have a history of kidney disease, liver disease, gastrointestinal disorders, or blood clotting disorders. Caution should be exercised in individuals with cardiac conditions, seizures, gastrointestinal disorders, hepatic or renal impairment, and dose adjustments or alternative treatments may be required. Pregnant and breastfeeding women should consult a doctor before taking it. It is crucial to complete the full course of treatment as prescribed and not to skip any doses, even if symptoms improve, to ensure the infection is fully treated. Geriatric and pediatric populations may require dosage adjustments. Consulting with a healthcare professional is crucial to ensure the safe and appropriate use of acebrophylline.

1. KD Tripathi, Essentials of Medical Pharmacology, Drugs for cough and bronchial asthma, 7th edition, 2013, 219
2. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Pulmonary pharmacology, 12th edition, 2011, 1040-1044
3. La Renon Healthcare Private Limited, [ Accessed on 17th June 2023], https://www.larenon.com/wp-content/uploads/2020/06/1.-Aphyren-N-LBL_ctc.pdf

The drug information on this page is different from medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.